Evidence-based Guideline Update: Medical Treatment of Infantile Spasms
Neurol 78:1974-1980, Go, C.Y.,et al, 2012
Vigabatrin Improves Paroxysmal Dystonia in Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 68:1320-1321, Leuzzi,V.,et al, 2007
Focal Lesion in the Splenium of the Corpus Callosum in Epileptic Patients:Antiepileptic Drug Toxicity
AJNR 20:125-129,131, Kim,S.S.,et al, 1999
Vigabatrin-Associated Retinal Cone System Dysfunction, Electroretinogram & Ophthalmol Findings
Neurol 50:614-618, Krauss,G.L.,et al, 1998
Acute Encephalopathy Associated with Vigabatrin Monotherapy in Patients with Mild Renal Failure
Neurol 51:314-315, Ifergane,G.,et al, 1998
New Antiepileptic Drugs
Arch Neurol 55:1181-1183, Bourgeois,B.F.D., 1998
New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996
New Antiepileptic Drugs:A Systematic Review of Their Efficacy and Tolerability
BMJ 313:1169-1174, 1157, 1158996., Marson,A.G.,et al, 1996
Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995
New Antiepileptic Drugs
Neurol 44:787-795, Harden,C.L., 1994
Vigabatrin
BMJ 300:277-278, 1990, Reynolds,E.H., 1990
Vigabatrin
Editorial, Lancet 1:532-5331989., , 1989